<https://rdf.molmedb.upol.cz/reference/ref3846> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM492552>,
		<https://identifiers.org/molmedb/MM00085>,
		<https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM00507>,
		<https://identifiers.org/molmedb/MM492399>;
	<http://purl.org/ontology/bibo/doi> "10.1021/jm101067y"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Wlodarczyk N, Le Broc-Ryckewaert D, Gilleron P, Lemoine A, Farce A, Chavatte P, Dubois J, Pommery N, Hénichart JP, Furman C, Millet R.: Potent farnesyltransferase inhibitors with 1,4-diazepane scaffolds as novel destabilizing microtubule agents in hormone-resistant prostate cancer. J Med Chem, Volume 54 (5), 2011"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM492551>;
	<http://purl.org/ontology/bibo/pmid> "21299244"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21> .
<https://rdf.molmedb.upol.cz/interaction/int1027486> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3846> .
<https://rdf.molmedb.upol.cz/interaction/int1028483> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3846> .
<https://rdf.molmedb.upol.cz/interaction/int1028568> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3846> .
<https://rdf.molmedb.upol.cz/interaction/int1028800> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3846> .
<https://rdf.molmedb.upol.cz/interaction/int1028801> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3846> .